These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Hyperphosphatemia. The hidden killer in chronic kidney disease. Askar AM Saudi Med J; 2015 Jan; 36(1):13-9. PubMed ID: 25629999 [TBL] [Abstract][Full Text] [Related]
31. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease]. Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189 [TBL] [Abstract][Full Text] [Related]
32. Dietary phosphorus, serum phosphorus, and cardiovascular disease. Menon MC; Ix JH Ann N Y Acad Sci; 2013 Oct; 1301():21-6. PubMed ID: 24117725 [TBL] [Abstract][Full Text] [Related]
33. [Phosphate metabolism and nutritional therapy in predialysis patients]. Hamada Y; Usami M Clin Calcium; 2012 Oct; 22(10):1577-82. PubMed ID: 23023639 [TBL] [Abstract][Full Text] [Related]
35. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat? Martin KJ; González EA Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848 [TBL] [Abstract][Full Text] [Related]
36. Lack of Awareness of Dietary Sources of Phosphorus Is a Clinical Concern. Shimada M; Shutto-Uchita Y; Yamabe H In Vivo; 2019; 33(1):11-16. PubMed ID: 30587596 [TBL] [Abstract][Full Text] [Related]
37. Mineral (Mal)Adaptation to Kidney Disease--Young Investigator Award Address: American Society of Nephrology Kidney Week 2014. Wolf M Clin J Am Soc Nephrol; 2015 Oct; 10(10):1875-85. PubMed ID: 26350436 [TBL] [Abstract][Full Text] [Related]
38. Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study. McGovern AP; de Lusignan S; van Vlymen J; Liyanage H; Tomson CR; Gallagher H; Rafiq M; Jones S PLoS One; 2013; 8(9):e74996. PubMed ID: 24040373 [TBL] [Abstract][Full Text] [Related]
39. Pathophysiology of Calcium, Phosphorus, and Magnesium Dysregulation in Chronic Kidney Disease. Felsenfeld AJ; Levine BS; Rodriguez M Semin Dial; 2015; 28(6):564-77. PubMed ID: 26303319 [TBL] [Abstract][Full Text] [Related]
40. Effects of phosphate on vascular function under normal conditions and influence of the uraemic state. Six I; Maizel J; Barreto FC; Rangrez AY; Dupont S; Slama M; Tribouilloy C; Choukroun G; Mazière JC; Bode-Boeger S; Kielstein JT; Drüeke TB; Massy ZA Cardiovasc Res; 2012 Oct; 96(1):130-9. PubMed ID: 22822101 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]